Baader Bank set a €72.00 ($83.72) price target on Fielmann (FRA:FIE) in a research note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
Several other analysts have also issued reports on FIE. Independent Research set a €72.00 ($83.72) target price on Fielmann and gave the stock a neutral rating in a report on Thursday, July 11th. Kepler Capital Markets set a €50.50 ($58.72) target price on Fielmann and gave the stock a sell rating in a report on Monday, April 29th. Berenberg Bank set a €57.00 ($66.28) target price on Fielmann and gave the stock a neutral rating in a report on Wednesday, May 22nd. HSBC set a €70.00 ($81.40) target price on Fielmann and gave the stock a neutral rating in a report on Friday, July 12th. Finally, Hauck & Aufhaeuser set a €41.00 ($47.67) target price on Fielmann and gave the stock a sell rating in a report on Friday, July 12th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. Fielmann currently has an average rating of Hold and a consensus target price of €60.41 ($70.24).
FIE opened at €60.45 ($70.29) on Tuesday. Fielmann has a 52-week low of €65.50 ($76.16) and a 52-week high of €77.50 ($90.12). The business’s fifty day moving average is €63.69 and its 200-day moving average is €61.71.
Fielmann Company Profile
Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.
Featured Story: Trading Ex-Dividend
Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.